公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2023 | Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study | CHIH-HSIN YANG ; Su, Wu-Chou; Chiu, Chao-Hua; Shiah, Her-Shyong; Lee, Kang-Yun; Hsia, Te-Chun; Uno, Makiko; Crawford, Nigel; Terakawa, Hiroshi; Chen, Wen-Chi; Takayama, Gensuke; Hsu, Ching; Hong, Ying; Saintilien, Carline; McGill, Joseph; Chang, Gee-Chen | Investigational new drugs | 2 | 2 |